Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Gross Profit
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
N
|
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707
|
Gross Profit
¥2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Gross Profit
¥9.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Gross Profit
¥4.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
18%
|
CAGR 10-Years
20%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Gross Profit
¥19.5B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
14%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Gross Profit
¥10.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Gross Profit
¥319.6m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Gross Profit?
Gross Profit
2B
CNY
Based on the financial report for Sep 30, 2023, Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Gross Profit amounts to 2B CNY.
What is Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
20%
Over the last year, the Gross Profit growth was 0%. The average annual Gross Profit growth rates for Nanjing King-friend Biochemical Pharmaceutical Co Ltd have been 7% over the past three years , 20% over the past five years .